News Briefing channel feed – Endpoints News

News Briefing channel feed

uniQure wins a BTD for hemophilia B therapy; Allergan scores sNDA for Avycaz

9 years ago

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

9 years ago

Endo axes R&D staff in restructuring; China biotech Connect raises $20 million

9 years ago

Zymeworks adds a new lab for fast-growing R&D work; Novartis considers a spinoff for Alcon

9 years ago

Regeneron buys its HQ site for $720M; Fast-growing Seattle Genetics plans 200 more hires this year

9 years ago

Bizarre takeover bid is dropped; Merck KGaA in licensing pact with Domain

9 years ago

Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now

9 years ago

Cytori bags Azaya drugs in asset purchase; Woodford offers a mea culpa on Northwest Bio

9 years ago

Merrimack recruits Sanofi vet Richard Peters for the top job; ObsEva and Braeburn detail their IPO shots

9 years ago

Upstart maps plans to build fibrosis pipeline; FDA extends review period for Lilly’s baricitinib

9 years ago

OncoImmune raises $15M for PhII GvHD study; FDA wraps biosimilar naming guidance

9 years ago

Biogen spinoff begins trading today; New oncology chief at AstraZeneca

9 years ago

Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A

9 years ago

Valeant auctions off Dendreon, skincare assets; Bayer to collaborate with the University of Pittsburgh

9 years ago

Amgen, Sanofi and Merck announce a string of deals at #JPM17; McDonough out at Sobi

9 years ago

Genentech vet Troy Cox named Foundation Med CEO; Momenta inks a $600M collaboration deal

9 years ago

Pieris soars on $31M-plus checkpoint development deal; Luca Santarelli takes helm at Therachon

9 years ago

scPharmacuticals raises $45M B round; Struggling Nivalis and Acura take stock of “strategic alternatives”

9 years ago

Braeburn Pharma files for $150M IPO; Tiziana in-licenses Novimmune antibody

9 years ago

Struggling OvaScience reorganizes, stock plunges; Chugai inks €130M deal; Ironwood, Allergan report new linaclotide CR2 data

9 years ago

Roche will have to wait on its big MS drug application; Pfizer ties up with BioInvent on new antibodies for cancer

9 years ago

Novartis adds opthalmology buyout in year-end deal spree; Tesaro gets a speedy FDA review for niraparib

9 years ago

Sanger spinout gets $10M, tackles the microbiome frontier; Adaptimmune and Bellicum partner T cell tech

9 years ago

Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space

9 years ago

First page Previous page 72 73 747576 77 78 Next page Last page